These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

364 related items for PubMed ID: 24314912

  • 1. Trends in pharmacotherapy in patients referred to a bipolar specialty clinic, 2000-2011.
    Hooshmand F, Miller S, Dore J, Wang PW, Hill SJ, Portillo N, Ketter TA.
    J Affect Disord; 2014 Feb; 155():283-7. PubMed ID: 24314912
    [Abstract] [Full Text] [Related]

  • 2. Healthcare costs associated with treatment of bipolar disorder using a mood stabilizer plus adjunctive aripiprazole, quetiapine, risperidone, olanzapine or ziprasidone.
    Jing Y, Kim E, You M, Pikalov A, Tran QV.
    J Med Econ; 2009 Jun; 12(2):104-13. PubMed ID: 19527195
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Risk of arrest in persons with schizophrenia and bipolar disorder in a Florida Medicaid program: the role of atypical antipsychotics, conventional neuroleptics, and routine outpatient behavioral health services.
    Van Dorn RA, Andel R, Boaz TL, Desmarais SL, Chandler K, Becker MA, Howe A.
    J Clin Psychiatry; 2011 Apr; 72(4):502-8. PubMed ID: 21527125
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effectiveness of aripiprazole, olanzapine, quetiapine, and risperidone augmentation treatment for major depressive disorder: a nationwide population-based study.
    Lin CY, Tsai GE, Wang HS, Wu YH, Chiou CC, Wu VY, Lane HY.
    J Clin Psychiatry; 2014 Sep; 75(9):e924-31. PubMed ID: 25295435
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents.
    Correll CU, Manu P, Olshanskiy V, Napolitano B, Kane JM, Malhotra AK.
    JAMA; 2009 Oct 28; 302(16):1765-73. PubMed ID: 19861668
    [Abstract] [Full Text] [Related]

  • 19. Long-term use of atypical antipsychotics in bipolar disorder.
    Ehret MJ, Levin GM.
    Pharmacotherapy; 2006 Aug 28; 26(8):1134-47. PubMed ID: 16863489
    [Abstract] [Full Text] [Related]

  • 20. Atypical antipsychotics related metabolic syndrome in bipolar patients.
    Yumru M, Savas HA, Kurt E, Kaya MC, Selek S, Savas E, Oral ET, Atagun I.
    J Affect Disord; 2007 Mar 28; 98(3):247-52. PubMed ID: 16970993
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.